27-Feb-2026
TipRanks (Fri, 27-Feb 8:20 AM ET)
PACS Group Inc (PACS) Gets a Buy from RBC Capital
TipRanks (Fri, 27-Feb 7:24 AM ET)
PACS Group GAAP EPS of $1.22, revenue of $5.29B
Seeking Alpha News (Fri, 27-Feb 6:54 AM ET)
PACS Group outlines 8% revenue growth target for 2026 as integration drives record year
Seeking Alpha News (Thu, 26-Feb 10:28 PM ET)
PACS Group, Inc. Reports Fiscal Year and Fourth Quarter 2025 Results
Business Wire (Thu, 26-Feb 4:15 PM ET)
PACS Group Intends to Release Fiscal Year and Fourth Quarter 2025 Earnings on February 26, 2026
Business Wire (Wed, 25-Feb 6:17 PM ET)
Business Wire (Tue, 20-Jan 5:41 PM ET)
Business Wire (Mon, 12-Jan 4:15 PM ET)
Business Wire (Mon, 8-Dec 4:12 PM ET)
PACS Group Announces Business Updates
Business Wire (Mon, 1-Dec 4:15 PM ET)
PACS Group Inc is a post-acute healthcare company mainly focused on delivering high-quality skilled nursing care through a portfolio of independently operated facilities Its is a nursing providers in the United States based on number of facilities, with over 200 post-acute care facilities across nine states serving over 20,000 patients daily. It also provide senior care, assisted living, and independent living options in some of communities.
Pacs Group trades on the NYSE stock market under the symbol PACS.
As of February 27, 2026, PACS stock price declined to $36.51 with 3,000,455 million shares trading.
PACS has a beta of 0.43, meaning it tends to be less sensitive to market movements. PACS has a correlation of 0.00 to the broad based SPY ETF.
PACS has a market cap of $5.72 billion. This is considered a Mid Cap stock.
Last quarter Pacs Group reported $1 billion in Revenue and $.49 earnings per share. This fell short of revenue expectation by $-12 million and exceeded earnings estimates by $.05.
The top ETF exchange traded funds that PACS belongs to (by Net Assets): VTI, AVUV, IWM, VB, VBK.
PACS has outperformed the market in the last year with a return of +179.8%, while the SPY ETF gained +18.5%. In the last 3 month period, PACS beat the market returning +13.5%, while SPY returned +1.2%. However, in the most recent 2 weeks PACS has underperformed the stock market by returning -3.4%, while SPY returned +0.6%.
PACS support price is $40.05 and resistance is $43.29 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PACS shares will trade within this expected range on the day.